<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02312193</url>
  </required_header>
  <id_info>
    <org_study_id>LMB02</org_study_id>
    <nct_id>NCT02312193</nct_id>
  </id_info>
  <brief_title>Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects</brief_title>
  <official_title>Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neuromed IRCCS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Neuromed IRCCS</source>
  <brief_summary>
    <textblock>
      Aim of this study is to enhance the knowledge of myogenic tone alterations in hypertensive&#xD;
      patients and to better understand the mechanisms controlling the myogenic tone. Evaluations&#xD;
      will be performed through ex vivo studies of peripheral arterioles in human adipose tissue&#xD;
      from lumbar muscle, isolated from biopsies. This will allow investigators to evaluate the&#xD;
      myogenic function in response to progressive blood pressure increases, in order to correlate&#xD;
      myogenic function to arterial hypertension and to the molecular mechanisms already identified&#xD;
      in the preclinical models.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Myogenic tone measured by micromyographic technique to evaluate small-artery morphology.</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">95</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Case</arm_group_label>
    <description>Hypertensive subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Normotensive subjects</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be selected from patients hospitalized in the Department of Neurosurgery of&#xD;
        the IRCCS Mediterranean Neurological Institute Neuromed, according to specific inclusion&#xD;
        criteria and undergoing surgery for disc disease. Subjects included in the study will be&#xD;
        normotensive and hypertensive patients. Approximately 70 subjects of both genders (35&#xD;
        normotensive, 35 hypertensive) aged between 30 and 70 years old will be included in the&#xD;
        study. All the enrolled patients must have an indication for neurosurgical intervention.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males or females between 30 and 70 years of age&#xD;
&#xD;
          -  Hypertensive patients: Patients with a previous diagnosis of hypertension&#xD;
&#xD;
          -  Normotensive patients: subjects without story of hypertension&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe hypertension (eg, systolic &gt;180 mm Hg, diastolic &gt;110 mm Hg)&#xD;
&#xD;
          -  Manifested or suspected secondary hypertension (coarctation of the aorta,&#xD;
             hyperaldosteronism, unilateral or bilateral renal artery stenosis, pheochromocytoma)&#xD;
&#xD;
          -  History of cardiac complications (previous acute myocardial infarction (AMI),&#xD;
             unstabile angina, percutaneous transluminal coronary angioplasty (PTCA), coronary&#xD;
             artery bypass grafting (CABG), congestive heart failure (NYHA II-IV))&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
          -  Renal pathologies (creatinine clearance &lt; 30 ml/min)&#xD;
&#xD;
          -  Severe hepatic dysfunction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Giuseppe Lembo, MD, PhD</last_name>
    <phone>+39 0865.915225</phone>
    <email>lembo@neuromed.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>IRCCS Neuromed</name>
      <address>
        <city>Pozzilli</city>
        <state>Isernia</state>
        <zip>86077</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Lembo, MD, PhD</last_name>
      <phone>+39 0865.915225</phone>
      <email>lembo@neuromed.it</email>
    </contact>
    <investigator>
      <last_name>Giuseppe Lembo, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lorenzo Carnevale, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>November 28, 2014</study_first_submitted>
  <study_first_submitted_qc>December 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2014</study_first_posted>
  <last_update_submitted>September 8, 2020</last_update_submitted>
  <last_update_submitted_qc>September 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Neuromed IRCCS</investigator_affiliation>
    <investigator_full_name>Giuseppe Lembo</investigator_full_name>
    <investigator_title>MD, Ph</investigator_title>
  </responsible_party>
  <keyword>hypertension</keyword>
  <keyword>myogenic tone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

